Resources for Food and Drug Administration (FDA)

FDA adds cancer warnings to J&J foot ulcer cream

ap.google.com

The Food and Drug Administration warned patients Friday that using large amounts of a Johnson & Johnson foot ulcer medication could heighten their risk of dying from cancer.

The FDA added its most serious warning to the company's cream medication Regranex, which is prescribed to treat severe foot and leg ulcers in diabetics. The new boxed warning states that patients who used three or more tubes of Regranex over a 20-month period were five times more likely to die of cancer.

When patients used lower amounts of the cream, the FDA said their chances of developing cancer were no higher than patients who had never used the drug.

View the Resource

Share or bookmarklet this web page at: